Package 71610-958-42

{"route": ["ORAL"], "spl_id": "445e4a36-0326-75ec-e063-6294a90aaa26", "openfda": {"nui": ["N0000182142", "N0000008832", "N0000182143", "N0000182141", "N0000185503"], "unii": ["GLH0314RVC"], "rxcui": ["1116635"], "spl_set_id": ["41c5d35c-91de-a8a4-e063-6394a90ac5ff"], "pharm_class_pe": ["Decreased Platelet Aggregation [PE]"], "pharm_class_epc": ["P2Y12 Platelet Inhibitor [EPC]"], "pharm_class_moa": ["P2Y12 Receptor Antagonists [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "P-Glycoprotein Inhibitors [MoA]"], "manufacturer_name": ["Aphena Pharma Solutions - Tennessee, LLC"]}, "finished": true, "packaging": [{"sample": false, "description": "5400 TABLET in 1 BOTTLE (71610-958-41)", "package_ndc": "71610-958-41", "marketing_start_date": "20251022"}, {"sample": false, "description": "1800 TABLET in 1 BOTTLE (71610-958-42)", "package_ndc": "71610-958-42", "marketing_start_date": "20251121"}], "brand_name": "Ticagrelor", "product_id": "71610-958_445e4a36-0326-75ec-e063-6294a90aaa26", "dosage_form": "TABLET", "pharm_class": ["Cytochrome P450 3A4 Inhibitors [MoA]", "Decreased Platelet Aggregation [PE]", "P-Glycoprotein Inhibitors [MoA]", "P2Y12 Platelet Inhibitor [EPC]", "P2Y12 Receptor Antagonists [MoA]"], "product_ndc": "71610-958", "generic_name": "Ticagrelor", "labeler_name": "Aphena Pharma Solutions - Tennessee, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Ticagrelor", "active_ingredients": [{"name": "TICAGRELOR", "strength": "90 mg/1"}], "application_number": "ANDA208584", "marketing_category": "ANDA", "marketing_start_date": "20250501", "listing_expiration_date": "20261231"}